KORU Medical Systems, Inc. (KRMD) company profile

KORU Medical Systems develops, manufactures, and commercializes mechanical infusion devices designed for subcutaneous drug delivery. Its core product line, the FREEDOM Infusion System, features the FREEDOM60 and FreedomEdge syringe drivers, subcutaneous safety needle sets, and precision flow rate tubing. These systems administer subcutaneous medications such as immunoglobulin for primary immunodeficiency and chronic inflammatory demyelinating polyneuropathy, alongside treatments for conditions like generalized myasthenia gravis. The business operates across three primary streams: domestic core, international core, and biopharmaceutical services, which offers testing and engineering support for clinical trials. The company provides its products and services to pharmaceutical firms, home infusion providers, specialty pharmacies, and distributors.

The company distributes its devices through three domestic distributors in the United States and six distributors internationally. It manufactures all infusion pumps and some consumables at its facility in Mahwah, New Jersey, while an external contract partner in Nicaragua produces additional consumables and maintains warehousing in Miami, Florida. KORU Medical Systems is headquartered in Mahwah, New Jersey.

Summary of the business section of KORU Medical Systems's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025, we had 73 full time employees, including 4 international”